Impact of errors in experimental parameters on reconstructed breast images using diffuse optical tomography
Open Access
- 13 February 2018
- journal article
- research article
- Published by Optica Publishing Group in Biomedical Optics Express
- Vol. 9 (3) , 1130-1150
Abstract
Near-infrared diffuse optical tomography (NIR-DOT) is an emerging technology that offers hemoglobin based, functional imaging tumor biomarkers for breast cancer management. The most promising clinical translation opportunities are in the differential diagnosis of malignant vs. benign lesions, and in early response assessment and guidance for neoadjuvant chemotherapy. Accurate quantification of the tissue oxy- and deoxy-hemoglobin concentration across the field of view, as well as repeatability during longitudinal imaging in the context of therapy guidance, are essential for the successful translation of NIR-DOT to clinical practice. The ill-posed and ill-condition nature of the DOT inverse problem makes this technique particularly susceptible to model errors that may occur, for example, when the experimental conditions do not fully match the assumptions built into the image reconstruction process. To evaluate the susceptibility of DOT images to experimental errors that might be encountered in practice for a parallel-plate NIR-DOT system, we simulated 7 different types of errors, each with a range of magnitudes. We generated simulated data by using digital breast phantoms derived from five actual mammograms of healthy female volunteers, to which we added a 1-cm tumor. After applying each of the experimental error types and magnitudes to the simulated measurements, we reconstructed optical images with and without structural prior guidance and assessed the overall error in the total hemoglobin concentrations (HbT) and in the HbT contrast between the lesion and surrounding area vs. the best-case scenarios. It is found that slight in-plane probe misalignment and plate rotation did not result in large quantification errors. However, any out-of-plane probe tilting could result in significant deterioration in lesion contrast. Among the error types investigated in this work, optical images were the least likely to be impacted by breast shape inaccuracies but suffered the largest deterioration due to cross-talk between signal channels. However, errors in optical images could be effectively controlled when experimental parameters were properly estimated during data acquisition and accounted for in the image processing procedure. Finally, optical images recovered using structural priors were, in general, less susceptible to experimental errors; however, lesion contrasts were more sensitive to errors when tumor locations were used as a priori info. Findings in this simulation study can provide guidelines for system design and operation in optical breast imaging studies.Keywords
Funding Information
- Massachusetts Life Sciences Center (MLSC) (Cooperative Research Matching Grant)
- National Cancer Institute (NCI) (R01CA142575, R01CA187595, R01CA204443)
- National Institute of Biomedical Imaging and Bioengineering (NIBIB) (R00EB011889)
This publication has 38 references indexed in Scilit:
- Diffuse Optical Monitoring of the Neoadjuvant Breast Cancer TherapyIEEE Journal of Selected Topics in Quantum Electronics, 2012
- Diffuse optical spectroscopic imaging correlates with final pathological response in breast cancer neoadjuvant chemotherapyPhilosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences, 2011
- Near-Infrared Optical Mammography for Breast Cancer Detection with Intrinsic ContrastAnnals of Biomedical Engineering, 2011
- Tumor Angiogenesis Change Estimated by Using Diffuse Optical Spectroscopic Tomography: Demonstrated Correlation in Women Undergoing Neoadjuvant Chemotherapy for Invasive Breast Cancer?Radiology, 2011
- Combined Optical and X-ray Tomosynthesis Breast ImagingRadiology, 2011
- In vivo quantitative imaging of normal and cancerous breast tissue using broadband diffuse optical tomographyMedical Physics, 2010
- Differentiation of benign and malignant breast tumors by in-vivo three-dimensional parallel-plate diffuse optical tomographyJournal of Biomedical Optics, 2009
- Assessing the future of diffuse optical imaging technologies for breast cancer managementMedical Physics, 2008
- Predicting response to breast cancer neoadjuvant chemotherapy using diffuse optical spectroscopyProceedings of the National Academy of Sciences, 2007
- Breast imaging technology: Probing physiology and molecular function using optical imaging - applications to breast cancerBreast Cancer Research, 2000